摘要WHO西太平洋区域传统、补充和整合医学（TCIM）历史悠久，普及度高，监管逐步建立，教研及贸易持续发展。日本、韩国、印度、中国通过资金支持、派遣医疗队、开展教学及义诊活动等模式进行援助，提升了西太平洋TCIM综合水平及本国TCIM国际影响力。但仍面临TCIM遗产保护不足、监管不力、循证研究缺乏及人才缺口等挑战。中医药在西太平洋TCIM发展中发挥着核心作用，今后发展与传播可通过借鉴日本、韩国、印度在标准化、品牌化、资金支持与教育推广等方面经验，完善知识产权保护，引领建立国际标准，鼓励非遗申报，探索多元资金支持，创新传播路径，深化中日韩多边协作，推动中医药本土化与国际化融合，更好提升中医药国际影响力。

abstractsTraditional, complementary, and integrative medicine (TCIM) in WHO Western Pacific Region boasts a rich legacy, widespread acceptance, and a dynamic trajectory of growth in teaching, research, and trade. The steadfast support from Japan, the Republic of Korea, India, and China—in the form of generous funding, skilled medical teams, and impactful educational and free clinic initiatives—has elevated the standard of TCIM in the Western Pacific and amplified the global prestige of their national medical traditions. Despite this progress, TCIM still faces significant challenges, including insufficient protection of its valuable heritage, gaps in regulation, a shortage of evidence-based research, and a pressing need for skilled professionals. TCM plays a central role in the development of TCIM in the Western Pacific. The future development and communication should learn from the experience of Japan, the Republic of Korea and India in standardization, branding, financial support and education promotion to secure stronger intellectual property rights, lead the creation of international standards, champion the recognition of its intangible cultural heritage, embrace innovative funding models and communication strategies, and deepen trilateral cooperation among China, Japan, and the Republic of Korea, in order to further drive the localization and globalization of TCM and enhance its international influence.